Company intelligence / Profile preview

Precision ADVANCE

Bethesda, MD, USA

Ownership: Private
Development stage: Other

Overview

Precision ADVANCE is a specialized business unit of Precision Medicine Group that provides comprehensive, end-to-end services for companies developing cell and gene therapies (CGT). The organization offers integrated solutions spanning clinical development, regulatory affairs, manufacturing and supply chain consulting, and commercialization strategy. By focusing exclusively on the unique complexities of advanced therapies, Precision ADVANCE helps biopharmaceutical innovators navigate the technical, clinical, and market access hurdles inherent in genomic medicine. Their expertise supports the entire product lifecycle, from early-stage development through to global patient delivery.

Modalities: Cell therapyGene therapyCAR-T cell therapymRNA-based drugsOncolytic virus therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Precision ADVANCE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision ADVANCE.

Explore the full profile